Atomoxetine Hydrochloride
Average across 58 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Dr.Reddy's laboratories Limited | unknown | 21 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 15 | SUPPLYING |
| Aurobindo Pharma Limited | generic | 15 | SUPPLYING |
| Creekwood Pharmaceuticals LLC | unknown | 14 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | generic | 14 | SUPPLYING |
| A-S Medication Solutions | repackager | 14 | SUPPLYING |
| Strides Pharma Science Limited | generic | 14 | SUPPLYING |
| Rising Pharma Holdings, Inc. | generic | 9 | SUPPLYING |
| NorthStar RxLLC | relabeler | 7 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 7 | SUPPLYING |
| NorthStar Rx LLC | relabeler | 7 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 7 | SUPPLYING |
| AvKARE | relabeler | 7 | SUPPLYING |
| Zydus Pharmaceuticals USA Inc. | generic | 6 | SUPPLYING |
| American Health Packaging | repackager | 2 | SUPPLYING |
+ 2 more labelers
Shortages, recalls, and registration changes attached to this drug concept.
Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule. — Recalling firm: Safecor Health, LLC — TX only
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide within the U.S
